Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Publications

Publications searcher

The science produced by our scientists is very important. In 2022, 1,629 papers were published in scientific journals with a global impact factor of over 15,000 points.

Blood eosinophil count predicts treatment failure and hospital readmission for COPD.

PMID: 33693048
Journal: ERJ open research
Year: 2020
Reference: ERJ Open Res. 2020 Nov 10;6(4). pii: 00188-2020. doi: 10.1183/23120541.00188-2020. eCollection 2020 Oct.
Impact factor: 0
Publication type: Paper in international publication
Authors: Kerkhof, Marjan, Chaudhry, Isha, Pavord, Ian D, Miravitlles, Marc, Kook Rhee, Chin, Halpin, David M G, Usmani, Omar S, Jones, Rupert, Kocks, Janwillem, Alacqua, Marianna et al.
DOI: 10.1183/23120541.00188-2020

Blood eosinophil count predicts treatment failure and hospital readmission for COPD.

PMID: 33693048
Journal: ERJ open research
Year: 2020
Reference: ERJ Open Res. 2020 Nov 10;6(4). pii: 00188-2020. doi: 10.1183/23120541.00188-2020. eCollection 2020 Oct.
Impact factor:
Publication type: Paper in international publication
Authors: Alacqua, Marianna; Chaudhry, Isha; Halpin, David M G; Jones, Rupert; Kaplan, Alan; Kerkhof, Marjan; Kocks, Janwillem; Kook Rhee, Chin; Miravitlles, Marc; Morris, Tamsin et al.
DOI: 10.1183/23120541.00188-2020

Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials.

PMID: 32943047
Journal: RESPIRATORY RESEARCH
Year: 2020
Reference: Respir Res. 2020 Sep 17;21(1):240. doi: 10.1186/s12931-020-01482-1.
Impact factor: 3.924
Publication type: Paper in international publication
Authors: Calverley, Peter M A, Chalmers, James D, Miravitlles, Marc, Xue, Wenqiong, Singh, Dave, Wedzicha, Jadwiga A, Siddiqui, Salman, de la Hoz, Alberto, Magnussen, Helgo et al.
DOI: 10.1186/s12931-020-01482-1

Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trials.

PMID: 32943047
Journal: RESPIRATORY RESEARCH
Year: 2020
Reference: Respir Res. 2020 Sep 17;21(1):240. doi: 10.1186/s12931-020-01482-1.
Impact factor:
Publication type: Paper in international publication
Authors: Calverley, Peter M A; Chalmers, James D; de la Hoz, Alberto; Magnussen, Helgo; Miravitlles, Marc; Siddiqui, Salman; Singh, Dave; Wedzicha, Jadwiga A; Xue, Wenqiong et al.
DOI: 10.1186/s12931-020-01482-1

Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF.

PMID: 31778751
Journal: JOURNAL OF HEPATOLOGY
Year: 2020
Reference: J Hepatol. 2020 Apr;72(4):688-701. doi: 10.1016/j.jhep.2019.11.009. Epub 2019 Nov 25.
Impact factor: 20.582
Publication type: Paper in international publication
Authors: Saliba, Faouzi, Moreau, Richard, Claria, Joan, Aguilar, Ferran, Fenaille, Francois, Lozano, Juanjo, Junot, Christophe, Colsch, Benoit, Caraceni, Paolo, Trebicka, Jonel et al.
DOI: 10.1016/j.jhep.2019.11.009

Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF.

PMID: 31778751
Journal: JOURNAL OF HEPATOLOGY
Year: 2020
Reference: J Hepatol. 2020 Apr;72(4):688-701. doi: 10.1016/j.jhep.2019.11.009. Epub 2019 Nov 25.
Impact factor:
Publication type: Paper in international publication
Authors: Aguilar, Ferran; Albillos, Agustin; Alessandria, Carlo; Angeli, Paolo; Arroyo, Vicente; Baldasarre, Maurizio; Banares, Rafael; Benten, Daniel; Bernal, William; Bernardi, Mauro et al.
DOI: 10.1016/j.jhep.2019.11.009

Blood-based biomarkers and stem cell therapy in human stroke: a systematic review.

PMID: 32638318
Journal: MOLECULAR BIOLOGY REPORTS
Year: 2020
Reference: Mol Biol Rep. 2020 Aug;47(8):6247-6258. doi: 10.1007/s11033-020-05627-9. Epub 2020 Jul 7.
Impact factor: 1.402
Publication type: Review in international publication
Authors: Pala, Elena, Bustamante, Alejandro, Jolkkonen, Jukka, Hommel, Marc, Rosell, Anna, Montaner, Joan et al.
DOI: 10.1007/s11033-020-05627-9

Blood-based biomarkers and stem cell therapy in human stroke: a systematic review.

PMID: 32638318
Journal: MOLECULAR BIOLOGY REPORTS
Year: 2020
Reference: Mol Biol Rep. 2020 Aug;47(8):6247-6258. doi: 10.1007/s11033-020-05627-9. Epub 2020 Jul 7.
Impact factor:
Publication type: Review in international publication
Authors: Bustamante, Alejandro; Hommel, Marc; Jolkkonen, Jukka; Montaner, Joan; Pala, Elena; Rosell, Anna et al.
DOI: 10.1007/s11033-020-05627-9

Bone marrow MSC from pediatric patients with B-ALL highly immunosuppress T-cell responses but do not compromise CD19-CAR T-cell activity.

PMID: 32868394
Journal: Journal for ImmunoTherapy of Cancer
Year: 2020
Reference: J Immunother Cancer. 2020 Aug;8(2). pii: jitc-2020-001419. doi: 10.1136/jitc-2020-001419.
Impact factor: 9.913
Publication type: Paper in international publication
Authors: Zanetti, Samanta Romina, Romecin, Paola Alejandra, Vinyoles, Meritxell, Juan, Manel, Fuster, Jose Luis, Camos, Mireia, Querol, Sergi, Delgado, Mario, Menendez, Pablo et al.
DOI: 10.1136/jitc-2020-001419

Bone marrow MSC from pediatric patients with B-ALL highly immunosuppress T-cell responses but do not compromise CD19-CAR T-cell activity.

PMID: 32868394
Journal: Journal for ImmunoTherapy of Cancer
Year: 2020
Reference: J Immunother Cancer. 2020 Aug;8(2). pii: jitc-2020-001419. doi: 10.1136/jitc-2020-001419.
Impact factor:
Publication type: Paper in international publication
Authors: Camos, Mireia; Delgado, Mario; Fuster, Jose Luis; Juan, Manel; Menendez, Pablo; Querol, Sergi; Romecin, Paola Alejandra; Vinyoles, Meritxell; Zanetti, Samanta Romina et al.
DOI: 10.1136/jitc-2020-001419

Bosutinib for pretreated patients with chronic phase chronic myeloid leukemia: primary results of the phase 4 BYOND study.

PMID: 32572189
Journal: LEUKEMIA
Year: 2020
Reference: Leukemia. 2020 Aug;34(8):2125-2137. doi: 10.1038/s41375-020-0915-9. Epub 2020 Jun 22.
Impact factor: 8.665
Publication type: Paper in international publication
Authors: Etienne, G, Garcia Gutierrez, V, Guerci-Bresler, A P, Hjorth-Hansen, H, Karsenti, J M, Kelly, K R, Le Coutre, P, Martinez Chamorro, C, Oehler, V G, Orti Pascual, G et al.
DOI: 10.1038/s41375-020-0915-9

Bosutinib for pretreated patients with chronic phase chronic myeloid leukemia: primary results of the phase 4 BYOND study.

PMID: 32572189
Journal: LEUKEMIA
Year: 2020
Reference: Leukemia. 2020 Aug;34(8):2125-2137. doi: 10.1038/s41375-020-0915-9. Epub 2020 Jun 22.
Impact factor:
Publication type: Paper in international publication
Authors: Abboud, Camille; Abruzzese, E; Akard, L P; Bardy-Bouxin, Nathalie; Bosi, A; Brummendorf, Tim H; Cervantes, F; Charbonnier, A; Di Raimondo, F; Ernst, Thomas et al.
DOI: 10.1038/s41375-020-0915-9

Both Epimutations and Chromosome Aberrations Affect Multiple Imprinted Loci in Aggressive Wilms Tumors.

PMID: 33217932
Journal: Cancers
Year: 2020
Reference: Cancers (Basel). 2020 Nov 18;12(11). pii: cancers12113411. doi: 10.3390/cancers12113411.
Impact factor:
Publication type: Paper in international publication
Authors: Acurzio, Basilia; Carella, Massimo; Cerrato, Flavia; de Alava, Enrique; Gallego, Soledad; Mora, Jaume; Palumbo, Orazio; Pignata, Laura; Riccio, Andrea; Roma, Josep et al.
DOI: 10.3390/cancers12113411

BRAF-mutant Transcriptional Subtypes Predict Outcome of Combined BRAF, MEK, and EGFR Blockade with Dabrafenib, Trametinib, and Panitumumab in Patients with Colorectal Cancer.

PMID: 32047001
Journal: CLINICAL CANCER RESEARCH
Year: 2020
Reference: Clin Cancer Res. 2020 Jun 1;26(11):2466-2476. doi: 10.1158/1078-0432.CCR-19-3579. Epub 2020 Feb 11.
Impact factor: 10.107
Publication type: Paper in international publication
Authors: Yoshino, Takayuki, Bendell, Johanna C, Hollebecque, Antoine, McRee, Autumn J, Siena, Salvatore, Gordon, Michael S, Tabernero, Josep, Yaeger, Rona, O'Dwyer, Peter J, De Vos, Filip et al.
DOI: 10.1158/1078-0432.CCR-19-3579

BRAF-mutant Transcriptional Subtypes Predict Outcome of Combined BRAF, MEK, and EGFR Blockade with Dabrafenib, Trametinib, and Panitumumab in Patients with Colorectal Cancer.

PMID: 32047001
Journal: CLINICAL CANCER RESEARCH
Year: 2020
Reference: Clin Cancer Res. 2020 Jun 1;26(11):2466-2476. doi: 10.1158/1078-0432.CCR-19-3579. Epub 2020 Feb 11.
Impact factor:
Publication type: Paper in international publication
Authors: Andre, Thierry; Atreya, Chloe E; Bendell, Johanna C; Brase, Jan C; Campbell, Catarina D; Corcoran, Ryan B; De Vos, Filip; Gasal, Eduard; Gordon, Michael S; Hollebecque, Antoine et al.
DOI: 10.1158/1078-0432.CCR-19-3579

Brain paraneoplastic syndromes in a patient with mediastinal ganglioneuroma.

PMID: 32944100
Journal: Radiology case reports
Year: 2020
Reference: Radiol Case Rep. 2020 Sep 2;15(11):2059-2062. doi: 10.1016/j.radcr.2020.08.010. eCollection 2020 Nov.
Impact factor: 0
Publication type: Letter or abstract
Authors: Escudero-Fernandez, Jose Migue, Garcia-Carpintero, Angel Sanchez-Montanez, Delgado-Alvarez, Ignacio, Castellote-Alonso, Amparo, Vazquez-Mendez, Elida Josefa et al.
DOI: 10.1016/j.radcr.2020.08.010

Brain paraneoplastic syndromes in a patient with mediastinal ganglioneuroma.

PMID: 32944100
Journal: Radiology case reports
Year: 2020
Reference: Radiol Case Rep. 2020 Sep 2;15(11):2059-2062. doi: 10.1016/j.radcr.2020.08.010. eCollection 2020 Nov.
Impact factor:
Publication type: Letter or abstract
Authors: Castellote-Alonso, Amparo; Delgado-Alvarez, Ignacio; Escudero-Fernandez, Jose Migue; Garcia-Carpintero, Angel Sanchez-Montanez; Vazquez-Mendez, Elida Josefa et al.
DOI: 10.1016/j.radcr.2020.08.010

Brain Penetration of Lorlatinib: Cumulative Incidences of CNS and Non-CNS Progression with Lorlatinib in Patients with Previously Treated ALK-Positive Non-Small-Cell Lung Cancer.

PMID: 32060867
Journal: Targeted Oncology
Year: 2020
Reference: Target Oncol. 2020 Feb;15(1):55-65. doi: 10.1007/s11523-020-00702-4.
Impact factor: 4.036
Publication type: Paper in international publication
Authors: Bauer, Todd M, Shaw, Alice T, Johnson, Melissa L, Navarro, Alejandro, Gainor, Justin F, Thurm, Holger, Pithavala, Yazdi K, Abbattista, Antonello, Peltz, Gerson, Felip, Enriqueta et al.
DOI: 10.1007/s11523-020-00702-4

Brain Penetration of Lorlatinib: Cumulative Incidences of CNS and Non-CNS Progression with Lorlatinib in Patients with Previously Treated ALK-Positive Non-Small-Cell Lung Cancer.

PMID: 32060867
Journal: Targeted Oncology
Year: 2020
Reference: Target Oncol. 2020 Feb;15(1):55-65. doi: 10.1007/s11523-020-00702-4.
Impact factor:
Publication type: Paper in international publication
Authors: Abbattista, Antonello; Bauer, Todd M; Felip, Enriqueta; Gainor, Justin F; Johnson, Melissa L; Navarro, Alejandro; Peltz, Gerson; Pithavala, Yazdi K; Shaw, Alice T; Thurm, Holger et al.
DOI: 10.1007/s11523-020-00702-4

Brain Tissue Oxygen and Cerebrovascular Reactivity in Traumatic Brain Injury: A Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury Exploratory Analysis of Insult Burden.

PMID: 32253987
Journal: JOURNAL OF NEUROTRAUMA
Year: 2020
Reference: J Neurotrauma. 2020 Sep 1;37(17):1854-1863. doi: 10.1089/neu.2020.7024. Epub 2020 May 4.
Impact factor: 3.793
Publication type: Paper in international publication
Authors: Sahuquillo, Juan, Czeiter, Endre, Czosnyka, Marek, Depreitere, Bart, Ercole, Ari, Frisvold, Shirin, Helbok, Raimund, Jankowski, Stefan, Kondziella, Danile, Koskinen, Lars-Owe et al.
DOI: 10.1089/neu.2020.7024

Brain Tissue Oxygen and Cerebrovascular Reactivity in Traumatic Brain Injury: A Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury Exploratory Analysis of Insult Burden.

PMID: 32253987
Journal: JOURNAL OF NEUROTRAUMA
Year: 2020
Reference: J Neurotrauma. 2020 Sep 1;37(17):1854-1863. doi: 10.1089/neu.2020.7024. Epub 2020 May 4.
Impact factor:
Publication type: Paper in international publication
Authors: Anke, Audny; Beer, Ronny; Bellander, Bo-Michael; Beqiri, Erta; Beqiri, Erta; Buki, Andras; Cabeleira, Manuel; Cabeleira, Manuel; Carbonara, Marco; Chieregato, Arturo et al.
DOI: 10.1089/neu.2020.7024

Brand-Specific Enhanced Safety Surveillance of GSK's Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain for the 2018/2019 Season.

PMID: 31884676
Journal: DRUG SAFETY
Year: 2020
Reference: Drug Saf. 2020 Mar;43(3):265-279. doi: 10.1007/s40264-019-00893-4.
Impact factor: 3.442
Publication type: Paper in international publication
Authors: Nguyen, Bach-Yen, Damaso, Silvia, Godderis, Lode, Martinez-Gomez, Xavier, Eckermann, Tamara, Loos, Hugo, Salamanca de la Cueva, Ignacio, Shende, Vishvesh, Schmidt, Alexander C, Yeakey, Anne et al.
DOI: 10.1007/s40264-019-00893-4

Brand-Specific Enhanced Safety Surveillance of GSK's Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain for the 2018/2019 Season.

PMID: 31884676
Journal: DRUG SAFETY
Year: 2020
Reference: Drug Saf. 2020 Mar;43(3):265-279. doi: 10.1007/s40264-019-00893-4.
Impact factor:
Publication type: Paper in international publication
Authors: Damaso, Silvia; Dos Santos, Gael; Eckermann, Tamara; Godderis, Lode; Loos, Hugo; Martinez-Gomez, Xavier; Nguyen, Bach-Yen; Salamanca de la Cueva, Ignacio; Schmidt, Alexander C; Shende, Vishvesh et al.
DOI: 10.1007/s40264-019-00893-4

Break in the Stroke Chain of Survival Due to COVID-19.

PMID: 32466738
Journal: STROKE
Year: 2020
Reference: Stroke. 2020 Aug;51(8):2307-2314. doi: 10.1161/STROKEAHA.120.030106. Epub 2020 May 29.
Impact factor: 7.19
Publication type: Paper in international publication
Authors: Gonzalez, Alejandro, Ruiz-Bayo, Lidia, Sanchez-Miura, Jose Antonio, Escudero-Martinez, Irene, Montaner, Joan, Barragan-Prieto, Ana, Perez-Sanchez, Soledad, Moniche, Francisco et al.
DOI: 10.1161/STROKEAHA.120.030106